Characteristics and outcomes of five patients with COVID-19 and hematological malignancies

Chiara Citterio; Antonio Lazzaro; Costanza Bosi; Maurice De Ponzio; Luigi Cavanna

doi:10.1002/ccr3.4013

Characteristics and outcomes of five patients with COVID-19 and hematological malignancies

Clin Case Rep. 2021 Jun 10;9(6):e04013. doi: 10.1002/ccr3.4013. eCollection 2021 Jun.

Authors

Chiara Citterio¹, Antonio Lazzaro², Costanza Bosi², Maurice De Ponzio³, Luigi Cavanna¹

Affiliations

¹ Oncology and Hematology Department Oncology Unit Piacenza General Hospital Piacenza Italy.
² Division of Hematology and Bone Marrow Transplant Center Piacenza General Hospital Piacenza Italy.
³ Pharmacy Unit Piacenza General Hospital Piacenza Italy.

Abstract

Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID-19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID-19 can overcome the infection, also in hematological patients.

Keywords: hematology; infectious diseases.

Publication types

Case Reports